Nottingham

This trial is looking at a different way of giving a combination of drugs called MATRix. It is for people with a primary lymphoma of the brain and spinal cord.

This study is looking at a pathway using the CanRisk assessment tool to assess breast cancer risk. The team are comparing this pathway to the usual pathway

This trial is looking at targeted drugs for bile duct cancer and gallbladder cancer that has spread to another part of the body or has come back after treatment

This trial is comparing new combinations of treatment with standard treatment for follicular lymphoma.

This trial is comparing BT113 and pembrolizumab to pembrolizumab alone, for squamous cell head and neck cancer.

This trial is looking at MK-2870 on its own or with pembrolizumab for people with breast cancer.

This trial is comparing stereotactic body radiotherapy to the prostate with stereotactic body radiotherapy to the prostate and lymph nodes in the pelvis.

This study will find out how endoscopic ultrasound helps doctors plan treatment when used with a CT scan and a PET-CT scan.